⌘K
Loading ticker…
As of 2026-08-24, SI-BONE, Inc. Common Stock (SIBN) has a 3-month relative strength percentile of 89 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.8%, relative volume 1.28×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
SIBN appears in 1 ETF as of Jun 2026: PSC at 0.05% weight, $1M notional.
Held by 42 ETFs · $57M across latest filings · largest weight 1.46% (SGRW).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.05% | $1M | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SIBN Jan avg: 6.28% median: 7.91% win: 50% σ: 19.39% n: 4 2022-04-12 → 2026-07-31 | SIBN Feb avg: 0.92% median: 0.86% win: 50% σ: 13.70% n: 4 2022-04-12 → 2026-07-31 | SIBN Mar avg: -11.84% median: -12.13% win: 0% σ: 10.45% n: 4 2022-04-12 → 2026-07-31 | SIBN Apr avg: -2.38% median: -2.71% win: 20% σ: 9.31% n: 5 2022-04-12 → 2026-07-31 | SIBN May avg: 7.91% median: 13.80% win: 60% σ: 23.38% n: 5 2022-04-12 → 2026-07-31 | SIBN Jun avg: 0.56% median: -0.42% win: 40% σ: 11.16% n: 5 2022-04-12 → 2026-07-31 | SIBN Jul avg: 2.83% median: 1.82% win: 60% σ: 10.73% n: 5 2022-04-12 → 2026-07-31 | SIBN Aug avg: 4.70% median: 3.61% win: 50% σ: 14.68% n: 4 2022-04-12 → 2026-07-31 (current) | SIBN Sep avg: -7.23% median: -9.43% win: 25% σ: 9.40% n: 4 2022-04-12 → 2026-07-31 | SIBN Oct avg: -2.28% median: -0.27% win: 50% σ: 13.00% n: 4 2022-04-12 → 2026-07-31 | SIBN Nov avg: 1.03% median: 4.86% win: 50% σ: 28.64% n: 4 2022-04-12 → 2026-07-31 | SIBN Dec avg: 6.55% median: 7.05% win: 100% σ: 4.90% n: 4 2022-04-12 → 2026-07-31 |